Exosomes – News and Features

Exosome appoints Bob Carter MD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board.

A study published in Nature Communications by researchers at Massachusetts General Hospital/Harvard Medical School shows that tumor microvesicles contain retro-transposons, also known as "jumping genes" as well as amplified oncogene sequences. These discoveries expand further on the use of microvesicles such as exosomes as a powerful blood-based cancer diagnostic medium.

NanoSight, world-leading manufacturers of unique nanoparticle characterization technology, will host an interactive webinar on the subject of exosome characterization by Nanoparticle Tracking Analysis.

Oxford researchers presented new data applying NTA to size and count both cellular microvesicles and exosomes at a low concentration.

Izon Science will unveil its latest breakthrough in nanoparticle analysis in the US this week.

The collaboration is based on the development of blood based companion diagnostics for key cancer gene mutations.

NanoSight’s methodologies aimed at measuring cellular nanoparticles in plasma and urine as biomarkers of a broad range of human disease conditions.